South Korea’s IP-backed lending market growth exceeds targets
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min
The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff
The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams
05 August 2021
Ten-figure awards in the patent space have caught capital’s attention, says Ocean Tomo's Ryan Zurek, but so has the IP market’s resilience in the face of economic turbulence
04 August 2021
The number and value of acquisitions have both tumbled further than in the early months of 2020
20 July 2021
An update to the country’s strategy recognises that facilitating ASEAN's patenting development is key
19 July 2021
Second quarter panels report finds a marked increase in negative views about the administration, but fewer covid concerns and signs of higher royalty and sales prices
01 July 2021
Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP
29 June 2021
Company president Joe Siino tells IAM the pool operator has secured virtually all the key innovators behind MPEG-H to roll out a unified licensing solution
23 June 2021
Globalisation in the 5G era has reduced the clout of portfolios centred on the country, but decisions taken by the government, the courts and in boardrooms have hastened the process
17 June 2021
Insurance giant, which recently announced a $400m IP fund, says it has a strong pipeline of lending deals in the works
17 June 2021
Latest Royalty Pharma investment shows is further evidence of the increasing IP monetisation options open to healthcare innovators
15 June 2021
Unlock unlimited access to all IAM content